HIV/AIDS has become a psychiatric epidemic. The disease causes or exacerbates such psychiatric disorders as depression, dementia, schizophrenia, and bipolar disease. At the same time, the presence of a psychiatric disorder can lead to increased risk for HIV infection and worsen the prognosis of patients once they are infected.

Dr. Glenn J. Treisman, who has been described as the "father of AIDS psychiatry," describes the relationship between psychiatric disorders and HIV/AIDS and demonstrates the ways in which effective recognition and treatment of mental disorders can increase a patient's ability to obtain better treatment, improve compliance with medical regimens, and reduce incidents of high-risk behavior.

The book provides HIV/AIDS professionals with overviews of psychiatric disorders, including mood and personality disorders, mental retardation, substance abuse and addiction, and sexual disorders and dysfunction. It also provides mental health professionals with essential information on how to care for patients with HIV and those at risk for the infection. The book discusses psychopharmacology, psychotherapy and counseling, as well as adherence and compliance issues, and the relationship between psychiatric disorders and other STDs. Containing the most up-to-date information on diagnosis, prognosis, and treatment, this book draws on the authors' unrivaled experience and uses case studies to show HIV/AIDS professionals how psychiatric interventions benefit the patient, the medical team, and society as a whole. The cases are rich and engaging, and convey to the reader the intense disorder that can affect the lives of patients.

Highly active antiretroviral therapy (HAART) is a therapeutic intervention developed by clinicians and researchers in order to fight the HIV pandemic. It has contributed to a significant reduction in AIDS-related mortality and allowed many previously bed-ridden patients to live healthier, more productive lives. Until the advent of HAART in 1996, a diagnosis of HIV infection was considered a death sentence. A decade later, the disease has been transformed into a serious, yet potentially manageable, medical condition for thousands of people living with HIV/AIDS in the developed world - almost overnight creating a generation of "HIV Survivors" - and forged a global movement to ensure that its Lazarus-like benefit reaches millions more in the developing world.
This book reviews the achievements of HAART over the past decade, and explores the challenges that may arise in the future. It recounts key landmarks in the development and introduction of HAART from the perspective of clinicians, researchers, economists, sociologists, and public policy experts, including the co-discoverers of HIV, Luc Montagnier and Robert Gallo. It explores the evolution of the disease, the evolution of HIV treatment, and the economic, social, and public policy impacts of both HIV and the introduction of HAART.

THE PIONEERING WORK IN HIV MEDICINE, COMPLETELY REVISED FOR THE FIRST TIME SINCE 2012 The 17th edition of Bartlett's Medical Management of HIV Infection offers the best-available clinical guidance for treatment of patients with HIV. Edited by preeminent and pioneering authorities in HIV research and clinical care, it has earned its status as the definitive work for physicians, physician assistants, nurse practitioners, pharmacists, and anyone working in the care of persons with HIV. Updated to reflect the most recent innovations in HIV prevention and therapy, this text balances new and old approaches to produce a guide to clinical management in any setting. Coverage includes: * New approaches to prevention of HIV and prevention of infection in patients with HIV * Laboratory protocols for screening and treatment * Antiretroviral therapies (including dosage and adverse effects and drug interactions ) * HIV treatment in resource-limited settings * Management of infections A portable, navigable guide to an exquisitely complex field, Bartlett's Medical Management of HIV Infection is the continuing standard for practice and education in the field of HIV.

This document is provided as an information resource for physicians and other health care professionals to guide them in the appropriate treatment of patients with HIV/AIDS. Recommendations for care and treatment change rapidly, and opinions can be controversial; therefore, physicians and other health care professionals are encouraged to consult other sources, especially manufacturers' package inserts, and confirm the information contained in these tables. The individual physician or other health care professional should use his/her best medical judgment in determining appropriate patient care or treatment because no single reference or service can take the place of medical training, education, and experience. Determination of appropriate treatment is the responsibility of the treating physician

People with HIV/AIDS can live longer, healthier lives because of advances in treatment of HIV infection. However, longer lives are associated with increased prevalence of 1) adverse effects of HIV infection, 2) adverse effects of the drugs used to treat HIV, and 3) concurrent medical conditions that would occur in the absence of HIV. These long-term complications have put HIV infection in the realm of chronic diseases rather than of infectious diseases, which usually respond to short-term clinical interventions. Effective management of chronic diseases in the primary care setting requires the coordination of interventions that occur at the level of the clinical services, the community supports for those clinical services, and the individual patient. While clinical services begin in the primary care clinic, community supports are needed, and the patient must be engaged to enhance self-management. The coordinated interventions together contribute to the desired clinical outcomes. The Chronic Care Model, which is used in the design and quality improvement activities of clinical services, conceptualizes how these factors impact the clinical outcome of chronic disease management. This book addresses several important aspects of HIV/AIDS care and treatment in a concise, accessible format; it is not meant to be a comprehensive reference book. Recommended references and citations are provided for the reader to be able to access in-depth information on topics that are particularly important and/or controversial. Appropriate use of antiretroviral drugs, treatment of opportunistic infections, symptom management, treatment of concurrent medical conditions, and other specific interventions to treat HIV disease and its complications are addressed. The format of this guide is designed to provide practical information for the common questions that arise in the care of patients with HIV infection. Recognizing the broader array of best practices that contribute to effective clinical outcomes among patients with a complex array of service needs, the authors also address patient evaluation, adherence, mental health, substance abuse, overall clinic management, and other factors that lead to improved patient outcomes according to the Chronic Care Model. Last, because the authors recognize the challenges of maintaining clinical practices in the face of rapidly changing and ever more complex treatment interventions, a chapter on sources for updated and in-depth clinical information is provided. Pediatric HIV/AIDS treatment is not addressed in this book.

When the fourth edition of The Guide to Living with HIV Infection was published in 1998, the effects of the new drugs against HIV were only beginning to be appreciated. Since that time, rates of hospitalization, serious illness, and death have dropped by 60 to 80 percent and have stayed down. Several years ago, one young woman with no remaining immune system had made the decision, despite her odds, to be kept alive artificially; she now lives a healthy life, has a near-normal immune system, and, for the last three years, has had no detectable HIV. Her world, and the world for most people affected by HIV infection, is radically changed.

In this new edition of their acclaimed guide, Dr. John Bartlett, director of the Infectious Diseases Division at the Johns Hopkins Hospital, and science writer Ann Finkbeiner thoroughly update their discussion of the disease, from the evolving issue of when to start treatment to the new and sophisticated tests for the response to treatment, for the state of the immune system, and for HIV's resistance to various drugs. They describe these drugs' unanticipated side effects, among which are changes in peoples' appearances and increases in the lipid levels of their blood. They offer advice on adhering to the drugs' regimen--a regimen so strict and demanding that even AIDS doctors, in trials using placebos, failed it. And they explain the medical strategies by which the levels of HIV can be pushed down to an undetectable level and made to stay there.

The authors emphasize the importance of receiving this good news cautiously. Though improvements in the drugs have made them easier to take, they still cost between $10,000 and $12,000 per year, and no oneknows whether HIV will develop resistance to them. New stresses accompany this uncertainty, and new perspectives accompany this new world. This latest Guide to Living with HIV Infection offers valuable advice both to those for whom treatment works and to those for whom it doesn't--all focused on remaining well as long as possible. The book continues to be the most complete source of medical, emotional, social, financial, and legal advice for people with HIV infection and for their families and friends.

New to this edition: ? Using the CD4 cell count and viral load tests to monitor response to treatment, to assess prognosis, and to indicate the state of the immune system ? New tests of HIV's resistance to the various drugs against HIV

? Advice on when to start treatment

? Strategy for achieving "no detectable virus"

? Tricks for adhering to the strict regimen required by the anti-HIV drugs

? New information on the unanticipated side effects of the anti-HIV drugs

? Advice to women with HIV infection who become pregnant ? New information on the risks of transmitting HIV

? Changes in emotional perspective resulting from living with HIV infection

? New guidelines for choosing a physician